Patient-Controlled Sedation in Port Implantation (PACSPI-2)

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions
PainPatient SatisfactionCancerVenous Puncture
Interventions
DRUG

Propofol + Alfentanil

In addition to LA, patients in the study group are able to self-administer a combination of propofol and alfentanil using a patient-controlled sedation pump. The pump enables the patient via a hand-held button to trigger the release of a single bolus of 0.5ml containing 4.5mg propofol and 25µg alfentanil under an 10second period. This results in a maximal possible amount of 6 bolus doses per minute.

Trial Locations (1)

555185

Länssjukhuset Ryhov, Jönköping

All Listed Sponsors
collaborator

Region Östergötland

OTHER

lead

Region Jönköping County

OTHER_GOV